Cipla, Cadila Healthcare, Glenmark Pharma: Technicals highlighted by Bonanza Portfolio
Vishal Wagh, Research Head at Bonanza Portfolio says that Nifty pharma has shown consistent outperformance to the major indices and the current pandemic environment is creating a large demand for the sector. He said that as per ranking based on its performance against the NIFTY and Nifty Pharma, Cadila, Glenmark, Cipla, Sun pharma, Divislab, Auropharma, Lupin and Dr Reddy will outperform in the sector whereas, Biocon, Alkem, APL and Granules may underperform
Vishal said that Cipla is currently all-time high and current sentiments are helping it to move further. On a weekly basis stock has cut all the major resistance and currently it is holding strongly: Reuters